FHIR IG analytics
| Package | hl7.fhir.uv.rwi-pharma |
| Resource Type | Task |
| Id | Task-scenario4-04-labelling-comments-round1.json |
| FHIR Version | R5 |
Resources that use this resource
No resources found
Resources that this resource uses
No resources found
Narrative
Note: links and images are rebased to the (stated) source
Labelling comments issued (round 1)
| Task | Labelling Comments (labelling-comments) |
|---|---|
| Procedure number | VAR-II-2027-0012 |
| Version | 1 |
| Status | requested |
| Business status | Labelling Comments Issued (labelling-comments-issued) |
| Requester | Health Authority – Regulatory Review Division |
| Owner | SynthPharma AG |
| Group identifier | urn:uuid:60ac55b8-8d46-58ff-b1b2-e8015d4960be |
| Authored | 2027-02-22T10:00:00+01:00 |
| Last modified | 2027-02-22T10:00:00+01:00 |
| Based on | scenario4-01-variation-submitted |
| Response due | 2027-03-04T23:59:59+01:00 |
Inputs (from the requester)
- Annotated ePI v2 (regulator comments, round 1)
labelling-comments
Outputs (from the owner)
None
Source1
{
"resourceType": "Task",
"id": "scenario4-04-labelling-comments-round1",
"meta": {
"versionId": "1",
"lastUpdated": "2027-02-22T10:00:00+01:00",
"profile": [
"http://hl7.org/fhir/uv/apix/StructureDefinition/apix-task"
]
},
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"identifier": [
{
"use": "official",
"type": {
"coding": [
{
"system": "http://hl7.org/fhir/uv/rwi-pharma/CodeSystem/apix-demo",
"code": "apixtaskinstance",
"display": "APIX Task Instance ID"
}
]
},
"system": "http://example.org/health-authority/task-id",
"value": "urn:uuid:8d04eb3f-cad1-5a30-aa90-894f6ea36577"
},
{
"use": "official",
"type": {
"coding": [
{
"system": "http://hl7.org/fhir/uv/rwi-pharma/CodeSystem/apix-demo",
"code": "apixregulatorprocedureno",
"display": "APIX Regulator Procedure Number"
}
]
},
"system": "http://example.org/health-authority/procedure-number",
"value": "VAR-II-2027-0012"
}
],
"basedOn": [
{
"reference": "Task/scenario4-01-variation-submitted"
}
],
"groupIdentifier": {
"use": "official",
"system": "http://example.org/health-authority/work-flow-group-id",
"value": "urn:uuid:60ac55b8-8d46-58ff-b1b2-e8015d4960be"
},
"status": "requested",
"businessStatus": {
"coding": [
{
"system": "http://hl7.org/fhir/uv/rwi-pharma/CodeSystem/apix-business-status",
"code": "labelling-comments-issued",
"display": "Labelling Comments Issued"
}
]
},
"intent": "proposal",
"priority": "routine",
"code": {
"coding": [
{
"system": "http://hl7.org/fhir/uv/rwi-pharma/CodeSystem/apix-task-code",
"code": "labelling-comments",
"display": "Labelling Comments"
}
]
},
"requestedPeriod": {
"start": "2027-02-22T10:00:00+01:00",
"end": "2027-03-04T23:59:59+01:00"
},
"authoredOn": "2027-02-22T10:00:00+01:00",
"lastModified": "2027-02-22T10:00:00+01:00",
"requester": {
"reference": "Organization/org-ema-srm-hmed",
"display": "Health Authority – Regulatory Review Division"
},
"owner": {
"reference": "Organization/org-synthpharma-ag",
"display": "SynthPharma AG"
},
"input": [
{
"type": {
"coding": [
{
"system": "http://hl7.org/fhir/uv/rwi-pharma/CodeSystem/apix-task-input-output-type",
"code": "labelling-comments",
"display": "Labelling Comments"
}
]
},
"valueReference": {
"reference": "DocumentReference/docref-epi-annotated-v2",
"display": "Annotated ePI v2 (regulator comments, round 1)"
}
}
]
}
FHIRsmith